Compare SNEX & COO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | SNEX | COO |
|---|---|---|
| Founded | 1924 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Ophthalmic Goods |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 16.1B |
| IPO Year | 1994 | N/A |
| Metric | SNEX | COO |
|---|---|---|
| Price | $95.68 | $82.12 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 11 |
| Target Price | N/A | ★ $88.55 |
| AVG Volume (30 Days) | 337.4K | ★ 3.1M |
| Earning Date | 02-04-2026 | 12-04-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 10.92 | N/A |
| EPS | ★ 5.89 | 1.87 |
| Revenue | ★ $130,897,700,000.00 | $4,092,400,000.00 |
| Revenue This Year | N/A | $6.56 |
| Revenue Next Year | $5.74 | $5.32 |
| P/E Ratio | ★ $16.15 | $43.83 |
| Revenue Growth | ★ 32.62 | 5.06 |
| 52 Week Low | $64.42 | $61.78 |
| 52 Week High | $106.98 | $100.24 |
| Indicator | SNEX | COO |
|---|---|---|
| Relative Strength Index (RSI) | 49.73 | 59.82 |
| Support Level | $95.36 | $81.92 |
| Resistance Level | $100.62 | $83.64 |
| Average True Range (ATR) | 2.96 | 1.27 |
| MACD | -0.05 | -0.30 |
| Stochastic Oscillator | 16.03 | 42.98 |
StoneX Group Inc is a Global brokerage and financial services firm. Its service offerings are execution, OTC / Market-Making, advisory services, Global payment solutions, market intelligence, Physical Trading and clearing services. The firm operates in four segments: Commercial, Institutional, Self-Directed/Retail, and Payments. Its customers include governmental and nongovernmental organizations, commercial banks, brokers, institutional investors, and investment banks. The company operates in the United States, South America, Europe, the Middle East and Asia, and other countries, out of which the majority of revenue is generated from the Middle East and Asia Region.
CooperCompanies is one of the largest eyecare companies in the US. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business with a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and Clariti, Cooper controls roughly one fourth of the US contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the US, and controls 17% of the US IUD market.